1. Home
  2. JYNT vs GOSS Comparison

JYNT vs GOSS Comparison

Compare JYNT & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Joint Corp.

JYNT

The Joint Corp.

HOLD

Current Price

$8.37

Market Cap

118.2M

Sector

Miscellaneous

ML Signal

HOLD

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$0.17

Market Cap

97.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JYNT
GOSS
Founded
2010
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
118.2M
97.5M
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
JYNT
GOSS
Price
$8.37
$0.17
Analyst Decision
Strong Buy
Buy
Analyst Count
2
8
Target Price
$17.00
$4.19
AVG Volume (30 Days)
74.1K
33.0M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
133.93
N/A
EPS
0.09
N/A
Revenue
$117,696,356.00
$48,471,000.00
Revenue This Year
$12.23
N/A
Revenue Next Year
N/A
$201.64
P/E Ratio
$93.00
N/A
Revenue Growth
15.49
N/A
52 Week Low
$7.50
$0.11
52 Week High
$11.22
$3.87

Technical Indicators

Market Signals
Indicator
JYNT
GOSS
Relative Strength Index (RSI) 40.89 48.66
Support Level $8.12 $0.14
Resistance Level $8.67 $0.19
Average True Range (ATR) 0.31 0.03
MACD -0.05 0.01
Stochastic Oscillator 8.91 36.66

Price Performance

Historical Comparison
JYNT
GOSS

About JYNT The Joint Corp.

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The company has one operating business segment; The Franchise Operations segment, which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the company's franchise license, which represents symbolic intellectual property.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).

Share on Social Networks: